Generation Health has two additional independent boards of leading clinical and genetic experts:
Clinical Advisory Board
Purpose:
The purpose of the Clinical Advisory Board is to provide independent opinion and oversight for the tests and policies that Generation Health is considering for inclusion in the GBM program.
Board Members
| Name |
Background |
| Judy Garber, M.D., MPH |
Director, Cancer Risk and Prevention Program
Associate Professor of Medicine, Harvard Medical School Department: Medical Oncology/Population Sciences Center/Program: Breast Oncology Center |
| Margaret Gulley, MD, FCAP |
Professor, Department of Pathology
University of North Carolina |
| Peter Honig, MD, MPH |
Senior VP, Worldwide Regulatory Affairs and Product Safety, Merck & Co.
Director, Office of Drug Safety Center for Drug Evaluation and Research, FDA |
| Jeffrey A. Kant, MD, PhD, FCAP, FAAAS |
Professor of Pathology and Human Genetics
Director, Division of Molecular Diagnostics
University of Pittsburgh Medical Center (UPMC) |
| Christopher Keeys, PharmD |
President, Clinical Pharmacy Associates
Associate Professor of Pharmacy, Howard University College of Pharmacy |
| David J. Kuter, MD, DPhil |
Professor of Medicine and Director, Center for Hematology
Massachusetts General Hospital and Harvard Medical School |
| Michael F. Murray, MD |
Clinical Chief of Genetics
Brigham & Women’s Hospital and Harvard Medical School |
| Douglas Owens, MD |
Professor of Medicine; Director, Stanford-UCSF Evidence-Based Practice Center
Stanford University |
| Silvia Priori, M.D., Ph.D. |
Director of the Cardiovascular Genetics Program
NYU - Langone Medical Center |
| Brian Smith, M.D. |
Professor and Chair of Laboratory Medicine
Professor of Internal Medicine and Pediatrics
Director, Immunology, Molecular Diagnostics and Flow Cytometry Laboratories
Director, Molecular Diagnostics
Yale School of Medicine |
| Christopher A. Walsh, MD, PhD |
Chief, Division of Genetics, Children's Hospital
Bullard Professor of Pediatrics and Neurology
Beth Israel Deaconess Medical Center & Harvard Medical School |
| Michael Weinblatt, MD |
John R. and Eileen K. Riedman Professor of Medicine
Harvard Medical School; Division of Rheumatology, Immunology and Allergy
Brigham and Women’s Hospital |
| Michael T Wong, MD |
Assistant Professor, Division of Infectious Diseases
Beth Israel Deaconess Medical Center & Harvard Medical School |
|
Patient Advisory and Public Policy Board (PAPB)
Purpose:
A team of independent professionals to advise Generation Health on public policy, patient and physician communications, and regulatory issues.
| Name |
Background |
| Arthur L. Caplan, Ph.D. |
Emanuel and Robert Hart Professor of Bioethics and the Director of the Center for Bioethics at the University of Pennsylvania in Philadelphia. |
| Deneen Vojta, M.D. |
Senior Vice President UnitedHealth Group |
| Lisa Salberg |
Founder and CEO, Hypertrophic Cardiomyopathy Association |
| Sue Friedman, DVM |
Founder and Executive Director, FORCE: Facing Our Risk of Cancer Empowered |
| Susannah Baruch, J.D. |
Policy Director and Consultant at Generations
Ahead, Consultant to Genetics and Public Policy Center, John Hopkins
University |
| Susanne B. Haga, Ph.D. |
Assistant Research Professor at Duke Institute for Genome Sciences & Policy |
 |
|
 |
| |
Generation Health's Mission
Generation Health will work on behalf of payors to manage a systematic, comprehensive, and cost-effective process for the administration of genetic testing benefits to control clients' costs and improve members' health.
|
|
 |
|
 |
|
|
|
|
